PARSIPPANY, N.J., Dec. 22, 2015 /PRNewswire/ -- PDI, Inc.(PDII) today reported that as the Company transitions to focusing solely on its molecular diagnostics operations, Nancy Lurker has resigned as ...

SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ: PDII), a pioneer in providing contract sales and commercial services to the biopharmaceutical industry, today announced the appointment of ...

NEW YORK--(BUSINESS WIRE)--Prolias Technologies, Inc. has filed suit against PDI Inc. (NASDAQ: PDII), a New Jersey-based company. PDI Inc. is alleged to have engaged breach of contract, breach of ...

PDI, Inc. (PDII) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the occasion, Nancy Lurker, Chief Executive Officer of PDI, Inc. (PDII), will preside over the NASDAQ ...

“With PD One, pharmaceutical marketers have a new tool that bridges the gap between the direct sales model and digital marketing, creating an entirely new communication channel to more effectively ...

As Parsippany-based health care commercialization company PDI Inc. transitions into a molecular diagnostics firm, it is making changes in its executive leadership, it announced Tuesday.First, Nancy ...

SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ: PDII - News), a pioneer in providing contract sales and commercialization services to the biopharmaceutical industry, today announced that PDI ...

PARSIPPANY -- Speaking to more than 30 members of the Executive Women of New Jersey (EWNJ) on June 4, Nancy Lurker, CEO of Parsippany-based, PDI Inc. (NASDAQ: PDII), shared personal experiences and ...

Parsippany-based health care commercialization company PDI Inc. announced Wednesday it has completed the sale of its commercial service business to Publicis Healthcare Communications Group for $25.5 ...

“With physicians adopting smartphones and other mobile devices even faster than the general population, we are moving quickly to meet their information demands across all key media,” said Jo Ann ...

PDI, Inc. PDII incurred operating loss of 44 cents in the second quarter of 2015, narrower than the Zacks Consensus Estimate of loss of 46 cents. Loss however winded year over year from 8 cents loss ...